Simvastatin could be new treatment option for patients with non-segmental vitiligo and dyslipidemia: Study
Egypt: For patients with nonsegmental vitiligo (NSV) and dyslipidemia, a daily regimen of simvastatin 80 mg could be a helpful treatment, is the conclusion drawn from a study published in Dermatologic...
Source: medicaldialogues.in